Dietary supplementation of selenoneine-containing tuna dark muscle extract effectively reduces pathology of experimental colorectal cancers in mice

Junko Masuda, Chiho Umemura, Miki Yokozawa, Ken Yamauchi, Takuya Seko, Michiaki Yamashita, Yumiko Yamashita

Research output: Contribution to journalArticle

4 Citations (Scopus)


Selenoneine is an ergothioneine analog with greater antioxidant activity and is the major form of organic selenium in the blood, muscles, and other tissues of tuna. The aim of this study was to determine whether a selenoneine-rich diet exerts antioxidant activities that can prevent carcinogenesis in two types of colorectal cancer model in mice. We administrated selenoneine-containing tuna dark muscle extract (STDME) to mice for one week and used azoxymethane (AOM) and dextran sodium sulfate (DSS) for inducing colorectal carcinogenesis. Next, we examined the incidence of macroscopic polyps and performed functional analysis of immune cells from the spleen. We also studied tumor formation rates and median survival following the subcutaneous implantation of a colorectal cancer cell line. In the AOM/DSS-induced colitis-associated cancer (CAC) model, the oral administration of STDME significantly decreased tumor incidence and inhibited the accumulation of myeloid-derived suppressor cells (MDSCs) while also inhibiting the downregulation of interferon-γ (IFN-γ) production during carcinogenesis. These results suggest that dietary STDME may be an effective agent for reducing colorectal tumor progression.

Original languageEnglish
Article number1380
Issue number10
Publication statusPublished - Oct 1 2018



  • Colorectal cancer
  • Myeloid-derived suppressor cells
  • Regulatory T cells
  • Selenoneine
  • Selenoneine-containing tuna dark muscle extract
  • Tumor growth

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this